SUMMIT THERAPEUTICS INC (SMMT) Stock Income Statement
NASDAQ:SMMT - Nasdaq - US86627T1088 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 710.00K | 1.81M | 860.00K | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 210.99M | 88.73M | 64.32M | 88.00M | 53.19M | |||
| Research and Development | 150.78M | 59.47M | 51.09M | 84.34M | 51.97M | |||
| Selling, General, and Administrative Expenses | 60.53M | 30.27M | 26.74M | 23.61M | 19.23M | |||
| Operating Income | -210.99M | -88.73M | -63.62M | -86.19M | -52.33M | |||
| Interest Income/Expense | 4.68M | -5.03M | -7.00M | -2.42M | -200.00K | |||
| Other Income/Expense | N/A | -252.00K | 300.00K | 0.00 | 480.00K | |||
| Non Recurring Items | -15.01M | -520.91M | -8.47M | 0.00 | -860.00K | |||
| Income Before Taxes | -221.31M | -614.93M | -78.78M | -88.60M | -52.91M | |||
| Income Tax | N/A | N/A | N/A | 0.00 | -210.00K | |||
| Net Income | -221.31M | -614.93M | -78.78M | -88.60M | -52.70M | |||
| EBITDA | -210.90M | -88.54M | -62.36M | -84.84M | -50.78M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.31 | -0.99 | -0.41 | -0.96 | -0.76 | |||
| Non GAAP EPS | -0.31 | -0.15 | N/A | N/A | -3.39 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | N/A | N/A | -11095.77% | -4895.03% | -6127.91% | |||
| Operating Profit Margin | N/A | N/A | -8960.56% | -4761.88% | -6084.88% | |||
All data in USD